Stockreport

Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF Oral podium presentation to highlight NeXT Personal® in colorectal cancer; Personalis to debut first data for Real-Time Variant Trackerâ„¢ to monitor therapy resistance du [Read more]